1
|
Aloiau A, Bobek BM, Caddell Haatveit K, Pearson KE, Watkins AH, Jones B, Smith CR, Ketcham JM, Marx MA, Harwood SJ. Stereoselective Amine Synthesis Mediated by a Zirconocene Hydride to Accelerate a Drug Discovery Program. J Org Chem 2024; 89:3875-3882. [PMID: 38422508 PMCID: PMC10949245 DOI: 10.1021/acs.joc.3c02723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Revised: 02/09/2024] [Accepted: 02/15/2024] [Indexed: 03/02/2024]
Abstract
Chiral amine synthesis remains a significant challenge in accelerating the design cycle of drug discovery programs. A zirconium hydride, due to its high oxophilicity and lower reactivity, gave highly chemo- and stereoselective reductions of sulfinyl ketimines. The development of this zirconocene-mediated reduction helped to accelerate our drug discovery efforts and is applicable to several motifs commonly used in medicinal chemistry. Computational investigation supported a cyclic half-chair transition state to rationalize the high selectivity in benzyl systems.
Collapse
Affiliation(s)
- Athenea
N. Aloiau
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | - Briana M. Bobek
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | | | - Kelly E. Pearson
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | - Ashlee H. Watkins
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | - Benjamin Jones
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | - Christopher R. Smith
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | - John M. Ketcham
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | - Matthew A. Marx
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| | - Stephen J. Harwood
- Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States
| |
Collapse
|
2
|
Achuenu C, Carret S, Poisson J, Berthiol F. Application of Chiral Sulfinamides into Formation and Reduction of Sulfinylketimines to Obtain Valuable α‐Chiral Primary Amines. European J Org Chem 2020. [DOI: 10.1002/ejoc.202000608] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Chukuka Achuenu
- Département de Chimie Moléculaire (SERCO) UMR CNRS‐UGA5250, ICMG FR‐2607 Université Grenoble Alpes 301 Rue de la Chimie, BP 53 38058 Grenoble Cedex 9 France
| | - Sébastien Carret
- Département de Chimie Moléculaire (SERCO) UMR CNRS‐UGA5250, ICMG FR‐2607 Université Grenoble Alpes 301 Rue de la Chimie, BP 53 38058 Grenoble Cedex 9 France
| | - Jean‐François Poisson
- Département de Chimie Moléculaire (SERCO) UMR CNRS‐UGA5250, ICMG FR‐2607 Université Grenoble Alpes 301 Rue de la Chimie, BP 53 38058 Grenoble Cedex 9 France
| | - Florian Berthiol
- Département de Chimie Moléculaire (SERCO) UMR CNRS‐UGA5250, ICMG FR‐2607 Université Grenoble Alpes 301 Rue de la Chimie, BP 53 38058 Grenoble Cedex 9 France
| |
Collapse
|